A novel model based on immune-related genes for differentiating biliary atresia from other cholestatic diseases
- PMID: 36502440
- DOI: 10.1007/s00383-022-05322-9
A novel model based on immune-related genes for differentiating biliary atresia from other cholestatic diseases
Abstract
Purpose: Based on a public gene expression database, this study established the immune-related genetic model that distinguished BA from other cholestasis diseases (DC) for the first time. We explored the molecular mechanism of BA based on the gene model.
Methods: The BA microarray dataset GSE46960, containing BA, other cause of intrahepatic cholestasis than biliary atresia and normal liver gene expression data, was downloaded from the Gene Expression Omnibus (GEO) database. We performed a comprehensive bioinformatics analysis to establish and validate an immune-related gene model and subsequently identified hub genes as biomarkers associated with the molecular mechanisms of BA. To assess the model's performance for separating BA from other cholestasis diseases, we used receiver operating characteristic (ROC) curves and the area under the curve (AUC) of the ROC. Independent datasets GSE69948 and GSE122340 were used for the validation process.
Results: The model was built using eight immune-related genes, including EDN1, HAMP, SAA1, SPP1, ANKRD1, MMP7, TACSTD2, and UCA1. In the GSE46960 and validation group, it presented excellent results, and the prediction accuracy of BA in comparison to other cholestasis diseases was good. Functional enrichment analysis revealed significant immunological differences between BA and other cholestatic diseases. Finally, we found that the TNFα-NF-κB pathway is associated with EDN1 gene expression and may explain fibrosis progression, which may become a new therapeutic target.
Conclusion: In summary, we have successfully constructed an immune-related gene model that can distinguish BA from other cholestatic diseases, while identifying the hub gene. Our exploration of immune genes provides new clues for the early diagnosis, molecular mechanism, and clinical treatment of biliary atresia.
Keywords: Biliary atresia; Cholestasis disease; Distinguish; Immune microenvironment; LASSO analysis; The genetic model.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Liquid chromatography-mass spectroscopy in the diagnosis of biliary atresia in children with hyperbilirubinemia.J Surg Res. 2018 Aug;228:228-237. doi: 10.1016/j.jss.2018.03.021. Epub 2018 Apr 11. J Surg Res. 2018. PMID: 29907216
-
Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia.Eur J Pediatr. 2022 Nov;181(11):3945-3953. doi: 10.1007/s00431-022-04612-7. Epub 2022 Sep 12. Eur J Pediatr. 2022. PMID: 36094664
-
Differentiating biliary atresia from other causes of infantile cholestasis: An appraisal of the histomorphological changes on liver biopsy.Indian J Pathol Microbiol. 2023 Oct-Dec;66(4):790-798. doi: 10.4103/ijpm.ijpm_215_22. Indian J Pathol Microbiol. 2023. PMID: 38084534
-
The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia.J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S23-9. doi: 10.1097/01.mpg.0000228197.28056.2f. J Pediatr Gastroenterol Nutr. 2006. PMID: 16819397 Review.
-
Role of Hepatobiliary Scintigraphy and Preoperative Liver Biopsy for Exclusion of Biliary Atresia in Neonatal Cholestasis Syndrome.Indian J Pediatr. 2017 Sep;84(9):685-690. doi: 10.1007/s12098-017-2408-z. Epub 2017 Jul 8. Indian J Pediatr. 2017. PMID: 28687948 Review.
Cited by
-
The correlation between rs2501577 gene polymorphism and biliary atresia: a systematic review and meta-analysis.Pediatr Surg Int. 2023 May 29;39(1):206. doi: 10.1007/s00383-023-05491-1. Pediatr Surg Int. 2023. PMID: 37248361
-
Correlation of the Expression Profile of Peripheral Leukocyte and Liver Tissue Immune Markers With Serum Liver Injury Indices in Children With Biliary Atresia.Mediators Inflamm. 2025 Apr 16;2025:9889239. doi: 10.1155/mi/9889239. eCollection 2025. Mediators Inflamm. 2025. PMID: 40270513 Free PMC article.
References
-
- Bezerra JA, Wells RG, Mack CL et al (2018) Biliary atresia: clinical and research challenges for the twenty-first century. Hepatology 68(3):1163–1173. https://doi.org/10.1002/hep.29905 - DOI - PubMed
-
- Amarachintha SP, Mourya R, Ayabe H et al (2022) Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia. Hepatology 75(1):89–103. https://doi.org/10.1002/hep.32107 - DOI - PubMed
-
- Betalli P, Cheli M, Colusso MM, et al. Association between Kasai portoenterostomy at low caseload centres and transplant complications in children with biliary atresia. J Pediatr Surg. Jan 10 2022;doi: https://doi.org/10.1016/j.jpedsurg.2021.12.030
-
- Taylor SA, Malladi P, Pan X, et al. Oligoclonal immunoglobulin repertoire in biliary remnants of biliary atresia. Sci Rep. Mar 14 2019;9(1):4508. doi: https://doi.org/10.1038/s41598-019-41148-7
-
- Zhang J, Luo Y, Feng M, Xia Q (2021) Identification of liver immune microenvironment-related hub genes in liver of biliary atresia. Front Pediatr 9:786422. https://doi.org/10.3389/fped.2021.786422 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous